Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for TECX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 13.19M
March 31, 2026 16.16M
December 31, 2025 9.709M
September 30, 2025 9.473M
June 30, 2025 11.55M
March 31, 2025 13.79M
December 31, 2024 12.13M
September 30, 2024 18.36M
June 30, 2024 27.54M
March 31, 2024 3.509M
December 31, 2023 124.04M
September 30, 2023 7.664M
June 30, 2023 11.80M
March 31, 2023 30.01M
December 31, 2022 28.58M
September 30, 2022 31.41M
June 30, 2022 27.90M
March 31, 2022 32.18M
Date Value
December 31, 2021 34.36M
September 30, 2021 22.88M
June 30, 2021 17.10M
March 31, 2021 12.98M
December 31, 2020 16.89M
September 30, 2020 25.38M
June 30, 2020 15.78M
March 31, 2020 13.20M
December 31, 2019 14.50M
September 30, 2019 10.44M
June 30, 2019 9.355M
March 31, 2019 10.58M
December 31, 2018 11.30M
September 30, 2018 6.163M
June 30, 2018 10.41M
March 31, 2018 6.227M
December 31, 2017 3.657M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 436.29M
Alnylam Pharmaceuticals, Inc. 4.205B
Anika Therapeutics, Inc. 46.19M
Savara, Inc. 48.48M
Vericel Corp. 132.82M

Total Liabilities (Quarterly) Related Metrics